BioMolecular Imaging provides Expert advice on anatomic & molecular imaging from entire organ systems to small molecules, peptides & antibodies for use in early clinical and clinical settings, trial design, data analysis, image reading as well as with all FDA liaisons, CROs and academic imaging sites.
Early Clinical & Late Clinical
Molecular and anatomic imaging continues to be an ever increasing and essential component of clinical drug trials.
BioMolecular Imaging can help your company navigate the complexities of biomarker development from preclinical research to FIH imaging to approval.
Past projects, Industry news, Selected publications
THERAPEUTICS & DIAGNOSTICS
BioMolecular Imaging has extensive, decades-long experience in anatomic and molecular imaging as applied to the conduct of therapeutic trials and the determination of drug efficacy.
Oncology, Brain, Biomarkers, Heart, Central Imaging Interpretation
DR. J. JAMES FROST
A long history in molecular and biomarker imaging...
Dr. J. James Frost received his M.D. and Ph.D. degrees from Washington University; his Ph.D. degree is in nuclear and radiochemistry. He is a board-certified radiologist and nuclear medicine physician. He also obtained an M.B.A. degree from Johns Hopkins University. Dr. Frost was an early pioneer in molecular imaging and led multiple projects at the John Hopkins Medicine Department of Radiology. These projects included outreach to pharma and biotech companies for collaboration on probe development and extension to clinical applications. Dr. Frost continues to play an active role in the biomedical imaging community from scholarly research to commercial applications in drug and diagnostic development, approval, and clinical implementation. Currently, Dr. Frost is President of BioMolecular Imaging and a Retired Professor at The Johns Hopkins University School of Medicine, Department of Radiology.
Molecular imaging Specialist
Clinical trials reader
Clinical radiology and nuclear medicine
Consulting for pharma, CROs, diagnostics, and biotech
Our company engaged Dr. Frost and BioMolecular Imaging as part of our team to plan, write and submit an exploratory IND for our new cancer imaging probe. He provided immeasurable help in identifying imaging CROs for the work and vetting each one in series on-site meetings. Our IND sailed through without revision.
CLINICAL IMAGING EXPERT
Served as the internal clinical imaging expert for a large public biotech company in a FIH clinical trial for a novel cancer imaging radiolabeled peptide.
ADVISORY BOARD CHAIR
Chaired an advisory board meeting for a large US corporation for post approval rollout and a new CNS probe-specific imaging workstation.
Evaluated U.S. imaging CRO’s for a large international CRO during a multi-month project to select an imaging CRO partner.